News ReleaseView printer-friendly version
Quidel to Present at Pacific Growth Equities Life Sciences Growth Conference on June 10 at 1:30 p.m. Pacific Time
SAN DIEGO, Jun 7, 2004 (BUSINESS WIRE) -- Quidel Corporation (Nasdaq:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, today announced that president and chief executive officer, S. Wayne Kay, will be a presenter at the Pacific Growth Equities Life Sciences Growth Conference at the Mark Hopkins Inter-Continental Hotel in San Francisco on Thursday, June 10, at 1:30 p.m. Pacific Time.
Investors may access an Internet Web cast of the presentation in the Investor Information section of the Company's Web site at www.quidel.com. The Web cast of the presentation and Q&A will be available for 30 days at the above Web address.
Quidel Corporation, a worldwide company helping women and their families live healthy lives, discovers, develops, manufactures and markets point-of-care (POC) rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions associated with women's health in areas such as reproduction, upper respiratory infections and other clinical conditions. Quidel provides a broad line of POC diagnostics for pregnancy and infectious diseases, including influenza A and B, Strep throat, pregnancy, H. pylori infection, chlamydia, infectious mononucleosis and infectious vaginitis. Quidel's products are sold to healthcare professionals for use in physician offices and clinical laboratories, and to consumers through several distribution partners. For more information, please visit www.quidel.com.
SOURCE: Quidel Corporation
Paul E. Landers, 858-552-7962
Lippert/Heilshorn & Associates
Ina McGuinness (firstname.lastname@example.org)
Bruce Voss (email@example.com)